Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when planning an ACL project calendar across ACL Rolling Review cycles, covering cycle selection against conference commitment windows, backward planning from an ARR deadline, the review-response-meta-review timeline, commitment decisions, resubmission loops to later cycles, and camera-ready through ACL Anthology publication.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
Use this as the project-management layer for an ACL paper. Unlike one-deadline conferences, ACL runs on a cycle-and-commit rhythm: pick an ARR cycle, ride its ~10-week review train, then decide at the commitment window whether to send the package to the conference or loop back for another cycle.
ACL is a conference with rotating per-edition program committees, not a journal: there is no standing editor and no APC. Costs are registration-based, and Anthology publication is free and open access.
ACL 2026 (64th edition, San Diego, July 2-7, 2026) drew from the ARR October 2025 and January 2026 cycles:
| Milestone | Date (verified for ACL 2026) |
|---|---|
| ARR January cycle submission | January 5, 2026 |
| Reviews + meta-reviews to authors | by March 9-10, 2026 |
| Commitment to ACL 2026 | March 14, 2026 |
| Acceptance notification | April 4, 2026 |
| Camera-ready | April 19, 2026 |
| Conference | July 2-7, 2026 |
The commitment table is the part authors get wrong, because it is set by ARR and not by
the conference: a cycle can only commit to the venues ARR lists against it, so "I will
aim for ACL" is a decision about which month to submit to ARR, often two or three
cycles ahead. As published on aclrollingreview.org/dates (re-read 2026-08-27):
| Venue | Final ARR submission | Commitment |
|---|---|---|
| EMNLP 2026 · AACL 2026 | May 25, 2026 | August 2, 2026 |
| EACL 2027 | August 3, 2026 | October 11, 2026 |
| NAACL 2027 · COLING 2027 | October 12, 2026 | December 20, 2026 |
| ACL 2027 (Kyoto, Aug 17-22, 2027) | January 2027 | not yet posted |
Two things follow that a reader working from the 2026 anchor above would get wrong. No 2026 cycle reaches ACL 2027 — the October 12 slot, the last one on the 2026 calendar, commits to NAACL and COLING. And the October 2026 cycle publishes only its submission date and its cycle end (December 20); every date in between is still TBA, so a plan that needs a known author-response window cannot use it yet.
Every date here is cycle-volatile, including the ones that are printed: re-read
aclrollingreview.org/dates before committing a team to any of them.
| Weeks out | Milestone for an experiments-heavy NLP paper |
|---|---|
| 8 | Claim fixed; datasets, baselines, and evaluation protocol frozen |
| 6 | Main results in; error-analysis sampling started |
| 4 | Human evaluation fielded; ablations running |
| 3 | Full draft in ACL style; internal red-team read |
| 2 | Responsible NLP checklist drafted against the real paper |
| 1 | Limitations written; anonymity sweep; supplement archive built |
| 0 | Submit early on deadline day (AoE) |
cycle N reviews weak?
-> revise (new experiments, rescoped claims)
-> cycle N+1 submission WITH: link to prior submission,
change summary, point-by-point response to old weaknesses
-> commit the stronger package to the next eligible conference
Budget one loop into any plan that matters: the modal strong ACL paper today has seen two cycles. Skipping the revision note is a desk reject; a floor meta-review score forbids quick resubmission without wholesale revision.
acl-camera-ready),
registration, presentation prep, artifact release.[Stage] planning / cycle-N under review / response window / commit window / accepted / revising
[Target] <conference + eligible ARR cycles, with dates and source>
[Critical path] <three tasks gating the next deadline>
[Loop budget] <cycles remaining before target conference>
[Owner map] <checklist/anonymity/supplement/response owners>
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。